LivWell administers highly accessible infusions and injections for patients suffering from compromised immune systems, infectious diseases, and other medical conditions and operates in five states.
Derek Spence, a partner at Frontline, said in an Aug. 16 news release from the firm that backing young companies is a proactive way to improve the quality, accessibility and cost of healthcare.
“LivWell delivers a patient-centric experience while being relentlessly focused on comprehensive support for physician partners. LivWell’s unique business model solves pain points for patients and providers and aligns completely with our strategy and approach of partnering with distributed healthcare companies,” Mr. Spence said.
The infusion services market is estimated to be more than $100 billion. More than 50 percent of infusions are administered within the hospital setting, where costs can be three to five times higher than similar treatments delivered in outpatient settings, according to the news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
